These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 27714586)
1. FCG (FLIPI, Charlson comorbidity index, and histological grade) score is superior to FLIPI in advanced follicular lymphoma. Mihaljevic B; Jelicic J; Andjelic B; Antic D; Markovic O; Petkovic I; Jovanovic MP; Trajkovic G; Bila J; Djurasinovic V; Sretenovic A; Vukovic V; Smiljanic M; Balint MT Int J Hematol; 2016 Dec; 104(6):692-699. PubMed ID: 27714586 [TBL] [Abstract][Full Text] [Related]
2. Correlation of the FLIPI score for follicular lymphoma with period of diagnosis and type of treatment. Arcaini L; Colombo N; Passamonti F; Burcheri S; Orlandi E; Brusamolino E; Della Porta M; Rumi E; Montanari F; Pascutto C; Paulli M; Lazzarino M Leuk Res; 2006 Mar; 30(3):277-82. PubMed ID: 16112730 [TBL] [Abstract][Full Text] [Related]
3. Follicular lymphoma patients with a high FLIPI score and a high tumor burden: a risk stratification model. Andjelić B; Todorović-Balint M; Antić D; Bila J; Djurašinović V; Mihaljević B Vojnosanit Pregl; 2015 Jan; 72(1):26-32. PubMed ID: 26043587 [TBL] [Abstract][Full Text] [Related]
4. Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry. Pastore A; Jurinovic V; Kridel R; Hoster E; Staiger AM; Szczepanowski M; Pott C; Kopp N; Murakami M; Horn H; Leich E; Moccia AA; Mottok A; Sunkavalli A; Van Hummelen P; Ducar M; Ennishi D; Shulha HP; Hother C; Connors JM; Sehn LH; Dreyling M; Neuberg D; Möller P; Feller AC; Hansmann ML; Stein H; Rosenwald A; Ott G; Klapper W; Unterhalt M; Hiddemann W; Gascoyne RD; Weinstock DM; Weigert O Lancet Oncol; 2015 Sep; 16(9):1111-1122. PubMed ID: 26256760 [TBL] [Abstract][Full Text] [Related]
5. Treatment outcomes and clinical relevance of the Follicular Lymphoma International Prognostic Index in Korean follicular lymphoma patients treated with chemotherapy. Maeng CH; Ahn SW; Ryu SY; Han S; Ko YH; Ji JH; Kim WS; Kim SJ Korean J Intern Med; 2016 May; 31(3):560-9. PubMed ID: 26898595 [TBL] [Abstract][Full Text] [Related]
6. Prognostic value of the Follicular Lymphoma International Prognostic Index score in marginal zone lymphoma: an analysis of clinical presentation and outcome in 144 patients. Heilgeist A; McClanahan F; Ho AD; Witzens-Harig M Cancer; 2013 Jan; 119(1):99-106. PubMed ID: 22736411 [TBL] [Abstract][Full Text] [Related]
7. The Follicular Lymphoma International Prognostic Index (FLIPI) and the histological subtype are the most important factors to predict histological transformation in follicular lymphoma. Giné E; Montoto S; Bosch F; Arenillas L; Mercadal S; Villamor N; Martínez A; Colomo L; Campo E; Montserrat E; López-Guillermo A Ann Oncol; 2006 Oct; 17(10):1539-45. PubMed ID: 16940035 [TBL] [Abstract][Full Text] [Related]
8. Is the follicular lymphoma international prognostic index better than the international prognostic index to identify high-risk follicular lymphoma patients? Etto LY; Silva VC; Inaoka RJ; Costa RP; Alves AC; Colleoni GW Leuk Lymphoma; 2007 Mar; 48(3):526-30. PubMed ID: 17454593 [TBL] [Abstract][Full Text] [Related]
9. Long-term outcomes of autologous stem cell transplantation for follicular non-Hodgkin lymphoma: effect of histological grade and Follicular International Prognostic Index. Vose JM; Bierman PJ; Loberiza FR; Lynch JC; Bociek GR; Weisenburger DD; Armitage JO Biol Blood Marrow Transplant; 2008 Jan; 14(1):36-42. PubMed ID: 18158959 [TBL] [Abstract][Full Text] [Related]
10. Utility of the Follicular Lymphoma International Prognostic Index and the International Prognostic Index in assessing prognosis and predicting first-line treatment efficacy in follicular lymphoma patients. Formica V; Norman AR; Cunningham D; Wotherspoon A; Oates J; Chong G Acta Haematol; 2009; 122(4):193-9. PubMed ID: 19887775 [TBL] [Abstract][Full Text] [Related]
11. PET/CT Assessment of Follicular Lymphoma and High Grade B Cell Lymphoma - Good Correlation with Clinical and Histological Features at Diagnosis. Novelli S; Briones J; Flotats A; Sierra J Adv Clin Exp Med; 2015; 24(2):325-30. PubMed ID: 25931367 [TBL] [Abstract][Full Text] [Related]
12. Follicular lymphoma in early stages: high risk of relapse and usefulness of the Follicular Lymphoma International Prognostic Index to predict the outcome of patients. Plancarte F; López-Guillermo A; Arenillas L; Montoto S; Giné E; Muntañola A; Ferrer A; Villamor N; Bosch F; Colomo L; Balaguer O; Campo E; Montserrat E Eur J Haematol; 2006 Jan; 76(1):58-63. PubMed ID: 16343272 [TBL] [Abstract][Full Text] [Related]
13. Validation, revision and extension of the Follicular Lymphoma International Prognostic Index (FLIPI) in a population-based setting. van de Schans SA; Steyerberg EW; Nijziel MR; Creemers GJ; Janssen-Heijnen ML; van Spronsen DJ Ann Oncol; 2009 Oct; 20(10):1697-702. PubMed ID: 19549712 [TBL] [Abstract][Full Text] [Related]
14. Predictive value of Follicular Lymphoma International Prognostic Index (FLIPI) in patients with follicular lymphoma at first progression. Montoto S; López-Guillermo A; Altés A; Perea G; Ferrer A; Camós M; Villela L; Bosch F; Esteve J; Cervantes F; Bladé J; Nomdedeu B; Campo E; Sierra J; Montserrat E Ann Oncol; 2004 Oct; 15(10):1484-9. PubMed ID: 15367408 [TBL] [Abstract][Full Text] [Related]
15. Follicular Lymphoma Evaluation Index (FLEX): A new clinical prognostic model that is superior to existing risk scores for predicting progression-free survival and early treatment failure after frontline immunochemotherapy. Mir F; Mattiello F; Grigg A; Herold M; Hiddemann W; Marcus R; Seymour JF; Bolen CR; Knapp A; Nielsen T; Casulo C Am J Hematol; 2020 Dec; 95(12):1503-1510. PubMed ID: 32815559 [TBL] [Abstract][Full Text] [Related]
16. The pretransplant Follicular Lymphoma International Prognostic Index is associated with survival of follicular lymphoma patients undergoing autologous hematopoietic stem cell transplantation. Keeney GE; Gooley TA; Pham RN; Press OW; Pagel JM; Petersdorf SH; Maloney DG; Bensinger W; Holmberg L; Gopal AK Leuk Lymphoma; 2007 Oct; 48(10):1961-7. PubMed ID: 17917964 [TBL] [Abstract][Full Text] [Related]
17. Serbian lymphoma study group: demografic characteristics of 257 patients with follicular lymphoma. Simonović O; Mačukanović-Golubović L; Andjelić B; Antić D; Mihaljević B Vojnosanit Pregl; 2015 Jun; 72(6):483-8. PubMed ID: 26226718 [TBL] [Abstract][Full Text] [Related]
19. First external validation of the FLIPI-L score in a single-center series of patients with follicular lymphoma. Mozas P; Rivero A; Rivas-Delgado A; Correa JG; Condom M; Nadeu F; Giné E; Delgado J; Villamor N; Campo E; Magnano L; López-Guillermo A Hematol Oncol; 2022 Apr; 40(2):297-301. PubMed ID: 34845733 [TBL] [Abstract][Full Text] [Related]
20. FcγRIIIA receptor genotype does not influence an outcome in patients with follicular lymphoma treated with risk-adapted immunochemotherapy. Prochazka V; Papajik T; Gazdova J; Divoka M; Rozmanova S; Faber E; Raida L; Kucerova L; Langova K; Jarosova M; Indrak K Neoplasma; 2011; 58(3):263-70. PubMed ID: 21395368 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]